|
End-of-day quote
Nasdaq
17/11/2026
|
5-day change | 1st Jan Change | ||
| 1.720 USD | -8.99% |
|
+2.99% | -80.95% |
| 11-16 | EnGene Therapeutics Inc. Presents at UBS Global Biopharma Conference 2026, Nov-16-2026 03:20 PM | |
| 11-13 | Leerink Partners Upgrades enGene to Outperform From Market Perform, $5 Price Target | MT |
Stock exchange
Quotes 5-day view: enGene Therapeutics Inc.
End-of-day quote Nasdaq| 11/11/2026 | 12/11/2026 | 13/11/2026 | 16/11/2026 | 17/11/2026 | |
|---|---|---|---|---|---|
| Last | $1.800 | $2.280 | $2.410 | $1.890 | $1.720 |
| Volume | 2,765,791 | 11,909,681 | 3,721,293 | 1,994,847 | 1,730,243 |
| Change | +7.78% | +26.67% | +5.70% | -21.58% | -8.99% |
| Opening | $1.700 | $1.930 | $2.410 | $2.320 | $1.890 |
| High | $1.810 | $2.350 | $2.510 | $2.356 | $1.950 |
| Low | $1.630 | $1.900 | $2.170 | $1.880 | $1.675 |
Performance
| 1 day | -8.99% | ||
| 1 week | +2.99% | ||
| Current month | +12.42% | ||
| 1 month | +2.99% | ||
| 3 months | +1.18% | ||
| Current year | -80.95% | ||
| 1 year | -78.66% | ||
| 3 years | -77.52% |
Volumes
marketsDaily volume
1,729,942
Avg. Volume 20 sessions
2,107,901
Avg. Volume 20 sessions USD
3,625,589.72
Record volume 1
51,454,331
Record volume 2
24,102,681
Record volume 3
17,386,929
Capital turnover ratio
0.03
Float rotation
0.03
Basic data
Market Cap (USD)
115,268,063
Net sales (USD)
0
Free-Float
99.89%
Free-Float capitalization (USD)
115,138,623
Average Daily Capital Traded
3.15%
Indicators
Moving average 5 days
2.02
Moving average 20 days
1.72
Moving average 50 days
1.79
Moving average 100 days
1.81
Price spread / (MMA5)
+17.44%
Price spread / (MMA20)
0.00%
Price spread / (MMA50)
+4.07%
Price spread / (MMA100)
+5.23%
STIM
RSI 9 days
46.44
RSI 14 days
48.15
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.99% | +2.99% | -78.66% | -77.52% | 115M | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| +0.96% | -1.51% | +9.33% | +91.30% | 58.86B | ||
| +0.80% | +0.42% | +25.93% | +86.56% | 55.22B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| -0.27% | -2.11% | +81.94% | +57.03% | 32.66B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | -1.28% | -2.50% | +23.81% | +147.42% | 40B | |
| Weighted average by Cap. | -0.18% | -2.18% | +34.92% | +146.93% |
Historical Quotes: enGene Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 1.68 | 2.51 | |
| 1 month | 1.45 | 2.51 | |
| Current year | 1.4 | 12.25 | |
| 1 year | 1.4 | 12.25 | |
| 3 years | 1.4 | 18.4 | |
| 5 years | 1.4 | 47.17 | |
| 10 years | 1.4 | 47.17 |
Monthly variations
Annual variations
| 2026 | -80.95% | ||
| 2025 | +35.79% | ||
| 2024 | -27.95% | ||
| 2023 | -10.65% | ||
| 2022 | +4.77% |
- Stock Market
- Stocks
- ENGN Stock
- Quotes enGene Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
















